Table 2.
Endemic area (Prevalence)£ |
Method (Type of DNA detection assay; gene target; biological sample) |
Reference |
Study population (N°) |
New test prevalence % (KK prevalence¶) |
Sensitivity % of new test (CI 95%) (Reference test) |
---|---|---|---|---|---|
High | rt-PCR (ITS2) Feces |
Al-Shehri et al. (32) | 258* SC |
67.4 (44,1) |
85 (78.4–89.9) (POC-CCA) |
90.2 (84.2–96.2) (LCA) |
|||||
LAMP (121-bp tandem repeat) Feces |
Mwangi et al. (33) | 383 SC |
45 (46) |
97.2 (93.5–98.8) (K-K) |
|
PCR-ELISA (121-bp tandem repeat) Urine |
Lodh et al.(34) | 100 GP |
89 (51) |
100 (95–100) (K-K/PCR) |
|
rt-PCR (121-bp tandem repeat) Feces |
Fuss et al. (35) | 305 SC |
92.9 (85.2) |
96.8 (94.9–98.8) (K-K) |
|
98.7 (96.5–100) (LCA) |
|||||
Moderate low | PCR-ELISA (121-bp tandem repeat) Feces |
Gomes et al. (36) | 206 GP |
30.1 (13.1) |
96.3 (81.7–99.8) (K-K) |
PCR (121-bp tandem repeat) Urine |
Enk et al. (7) | 194 GP |
41.2 (13.9) |
100 (94.7–100) (Combined 1**) |
|
Low | SmMIT-LAMP (mitochondrial S. mansoni minisatellite DNA region) Feces |
Gandasegui et al. (37) | 427* GP |
30.2 (3.04) |
92.9 (66.1–99.8) (K-K) |
r-t PCR (COX-1) Feces |
Cavalcanti et al. (30) | 108 GP |
29.6 (7.4) |
100 (63.1–100) (K-K) |
|
PCR (121-bp tandem repeat) Urine |
Hessler et al. (38) | 111 SC |
78 (8.0) |
100 (96–100) (K-K) |
Classified according WHO; rt-PCR, Real-Time Polymerase Chain Reaction; LAMP, Loop-Mediated Isothermal Amplification Assay; SmMIT-LAMP, Sm Mitochondrial Loop-Mediated Isothermal Amplification Assay; SC, School Children; GP, General Population; KK, Kato-Katz test; POC-CCA, Point-of-Care platform for detection of cathodic circulating antigen; LCA, Latent Class Analysis;
KK duplicate (Two slides/sample);
Number of tested samples;
Combined 1(parasitological tests): KK, Saline Gradient and the Miracidia Hatch test served as combined reference test.